Can a new hemophilia drug help patients live more active lives?
NCT ID NCT06530030
Summary
This study aimed to see if a preventive treatment for moderate or severe hemophilia A helps patients achieve personal goals and become more physically active. It planned to observe 35 patients aged 12-50 in the US and Japan who were newly starting this treatment. The study was terminated early, having enrolled only 3 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bleeding and Clotting Disorders Institute
Peoria, Illinois, 61614, United States
Conditions
Explore the condition pages connected to this study.